NO974403D0 - Reversible proteasehemmere - Google Patents
Reversible proteasehemmereInfo
- Publication number
- NO974403D0 NO974403D0 NO974403A NO974403A NO974403D0 NO 974403 D0 NO974403 D0 NO 974403D0 NO 974403 A NO974403 A NO 974403A NO 974403 A NO974403 A NO 974403A NO 974403 D0 NO974403 D0 NO 974403D0
- Authority
- NO
- Norway
- Prior art keywords
- protease inhibitors
- reversible protease
- reversible
- inhibitors
- protease
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/16—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms
- C07D295/20—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms by radicals derived from carbonic acid, or sulfur or nitrogen analogues thereof
- C07D295/215—Radicals derived from nitrogen analogues of carbonic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C317/00—Sulfones; Sulfoxides
- C07C317/26—Sulfones; Sulfoxides having sulfone or sulfoxide groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton
- C07C317/28—Sulfones; Sulfoxides having sulfone or sulfoxide groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton with sulfone or sulfoxide groups bound to acyclic carbon atoms of the carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic System
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/6527—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having nitrogen and oxygen atoms as the only ring hetero atoms
- C07F9/6533—Six-membered rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/10—Tetrapeptides
- C07K5/1002—Tetrapeptides with the first amino acid being neutral
- C07K5/1016—Tetrapeptides with the first amino acid being neutral and aromatic or cycloaliphatic
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US40999695A | 1995-03-24 | 1995-03-24 | |
PCT/US1996/003844 WO1996030353A1 (en) | 1995-03-24 | 1996-03-21 | Reversible protease inhibitors |
Publications (3)
Publication Number | Publication Date |
---|---|
NO974403D0 true NO974403D0 (no) | 1997-09-23 |
NO974403L NO974403L (no) | 1997-11-17 |
NO311573B1 NO311573B1 (no) | 2001-12-10 |
Family
ID=23622800
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO19974403A NO311573B1 (no) | 1995-03-24 | 1997-09-23 | Reversible proteasehemmere |
Country Status (15)
Country | Link |
---|---|
EP (1) | EP0817778A1 (no) |
JP (1) | JPH11503417A (no) |
KR (1) | KR19980703261A (no) |
CN (1) | CN1071751C (no) |
AU (1) | AU713492B2 (no) |
CA (1) | CA2216151A1 (no) |
CZ (1) | CZ298197A3 (no) |
IL (1) | IL117638A0 (no) |
MY (1) | MY113489A (no) |
NO (1) | NO311573B1 (no) |
NZ (1) | NZ305626A (no) |
PL (1) | PL322409A1 (no) |
TW (1) | TW470750B (no) |
WO (1) | WO1996030353A1 (no) |
ZA (1) | ZA962336B (no) |
Families Citing this family (28)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1997040066A1 (en) | 1996-04-22 | 1997-10-30 | Massachusetts Institute Of Technology | Suppression of immune response via inhibition of cathepsin s |
SK8599A3 (en) * | 1996-07-30 | 2000-03-13 | Arris Pharm Corp | Disubstituted cyclic compound, process for its preparation, pharmaceutical composition and method of the treatment of an animal |
DE19817461A1 (de) | 1998-04-20 | 1999-10-21 | Basf Ag | Neue substituierte Benzamide, deren Herstellung und Anwendung |
JP2002538151A (ja) | 1999-03-02 | 2002-11-12 | ベーリンガー インゲルハイム ファーマシューティカルズ インコーポレイテッド | カテプシンの可逆的インヒビターとして有用な化合物 |
US6420364B1 (en) | 1999-09-13 | 2002-07-16 | Boehringer Ingelheim Pharmaceuticals, Inc. | Compound useful as reversible inhibitors of cysteine proteases |
DK1218372T3 (da) * | 1999-09-13 | 2003-10-20 | Boehringer Ingelheim Pharma | Nye heterocykliske forbindelser, der er anvendelige som reversible inhibitorer af cysteinproteaser |
EP1230349B1 (en) | 1999-11-18 | 2007-06-13 | Dendreon Corporation | Nucleic acids encoding endotheliases, endotheliases and uses thereof |
US7700341B2 (en) | 2000-02-03 | 2010-04-20 | Dendreon Corporation | Nucleic acid molecules encoding transmembrane serine proteases, the encoded proteins and methods based thereon |
JP4911864B2 (ja) | 2000-08-14 | 2012-04-04 | オーソ−マクニール・フアーマシユーチカル・インコーポレーテツド | 置換ピラゾール |
AU8645401A (en) | 2000-08-14 | 2002-02-25 | Ortho Mcneil Pharm Inc | Substituted pyrazoles |
US7332494B2 (en) | 2000-08-14 | 2008-02-19 | Janssen Pharmaceutica, N.V. | Method for treating allergies using substituted pyrazoles |
JP5140225B2 (ja) | 2000-08-14 | 2013-02-06 | オーソ−マクニール・フアーマシユーチカル・インコーポレーテツド | 置換ピラゾール |
RU2003106192A (ru) | 2000-09-06 | 2004-07-27 | Орто-Макнейл Фармасьютикал, Инк. (Us) | Способ лечения аллергий |
WO2002048097A1 (en) * | 2000-12-12 | 2002-06-20 | Corvas International, Inc. | Compounds, compositions and methods for treatment of parasitic infections |
JP2004523506A (ja) | 2000-12-22 | 2004-08-05 | アクシス・ファーマシューティカルズ・インコーポレイテッド | カテプシン阻害剤としての新規な化合物と組成物 |
US7030116B2 (en) | 2000-12-22 | 2006-04-18 | Aventis Pharmaceuticals Inc. | Compounds and compositions as cathepsin inhibitors |
US6900237B2 (en) | 2001-09-14 | 2005-05-31 | Axys Pharmaceuticals, Inc. | Sulfonamide compounds as protease inhibitors |
PL369312A1 (en) * | 2001-09-14 | 2005-04-18 | Aventis Pharmaceuticals Inc. | Novel compounds and compositions as cathepsin inhibitors |
YU34604A (sh) | 2001-11-14 | 2006-08-17 | Aventis Pharmaceuticals Inc. | Oligopeptidi kao inhibitori katepsina s i kompozicije koje ih sadrže |
GB0311406D0 (en) * | 2003-05-17 | 2003-06-25 | Queen Mary & Westfield College | Substituted phosphonate fluorescent sensors,and use thereof |
AU2009250295B2 (en) | 2008-05-21 | 2014-05-01 | Genesis Technologies Limited | Selective caspase inhibitors and uses thereof |
US9045524B2 (en) | 2009-05-21 | 2015-06-02 | Novagenesis Foundation | Selective caspase inhibitors and uses thereof |
US8895497B2 (en) | 2009-12-04 | 2014-11-25 | Dcb-Usa, Llc | Cathepsin S inhibitors |
EP2697246B1 (en) | 2011-04-15 | 2018-03-07 | Genesis Technologies Limited | Selective cysteine protease inhibitors and uses thereof |
KR101309578B1 (ko) * | 2011-05-06 | 2013-09-17 | 연세대학교 산학협력단 | 시스테인 프로테아제 선택성을 갖는 다이타이로신 화합물 및 이를 이용한 시스테인 프로테아제의 검출방법 |
KR101385855B1 (ko) * | 2012-10-16 | 2014-04-22 | 이동익 | 카뎁신 검출용 다이아로마틱 아미노산 기질 |
WO2019142890A1 (ja) * | 2018-01-19 | 2019-07-25 | 株式会社大阪ソーダ | 有機珪素化合物、及びそれを用いたゴム組成物 |
EP3553521A1 (en) * | 2018-04-12 | 2019-10-16 | Koninklijke Philips N.V. | Gingivitis diagnostic methods, uses and kits |
-
1996
- 1996-03-21 CN CN96193951A patent/CN1071751C/zh not_active Expired - Fee Related
- 1996-03-21 WO PCT/US1996/003844 patent/WO1996030353A1/en not_active Application Discontinuation
- 1996-03-21 CZ CZ972981A patent/CZ298197A3/cs unknown
- 1996-03-21 PL PL96322409A patent/PL322409A1/xx unknown
- 1996-03-21 NZ NZ305626A patent/NZ305626A/xx unknown
- 1996-03-21 AU AU53674/96A patent/AU713492B2/en not_active Ceased
- 1996-03-21 CA CA002216151A patent/CA2216151A1/en not_active Abandoned
- 1996-03-21 EP EP96910499A patent/EP0817778A1/en not_active Withdrawn
- 1996-03-21 JP JP8529509A patent/JPH11503417A/ja active Pending
- 1996-03-21 KR KR1019970706665A patent/KR19980703261A/ko not_active Application Discontinuation
- 1996-03-22 MY MYPI96001076A patent/MY113489A/en unknown
- 1996-03-22 ZA ZA962336A patent/ZA962336B/xx unknown
- 1996-03-24 IL IL11763896A patent/IL117638A0/xx unknown
- 1996-04-12 TW TW085104392A patent/TW470750B/zh active
-
1997
- 1997-09-23 NO NO19974403A patent/NO311573B1/no not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
WO1996030353A1 (en) | 1996-10-03 |
AU5367496A (en) | 1996-10-16 |
TW470750B (en) | 2002-01-01 |
CA2216151A1 (en) | 1996-10-03 |
JPH11503417A (ja) | 1999-03-26 |
ZA962336B (en) | 1996-07-31 |
MY113489A (en) | 2002-03-30 |
CZ298197A3 (cs) | 1998-03-18 |
EP0817778A1 (en) | 1998-01-14 |
KR19980703261A (ko) | 1998-10-15 |
IL117638A0 (en) | 1996-07-23 |
NO311573B1 (no) | 2001-12-10 |
NO974403L (no) | 1997-11-17 |
NZ305626A (en) | 2000-01-28 |
CN1184472A (zh) | 1998-06-10 |
AU713492B2 (en) | 1999-12-02 |
CN1071751C (zh) | 2001-09-26 |
PL322409A1 (en) | 1998-01-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO20006716D0 (no) | Proteaseinhibitorer | |
NO974403L (no) | Reversible proteasehemmere | |
NO975742D0 (no) | Reversible cysteinproteasehemmere | |
NO995433D0 (no) | Protease-inhibitorer | |
PT936912E (pt) | Inibidores de cisteina protease | |
FI962315A (fi) | Entsyymi-inhibiittorit | |
NO932620D0 (no) | Amindiol-proteaseinhibitorer | |
FI963597A0 (fi) | Isoprenyylitransferaasi-inhibiittoreita | |
NO972930D0 (no) | Fibronectin-adhesjonsinhibitorer | |
FI973282A (fi) | Trombiinin inhibiittoreita | |
NO942064D0 (no) | yminhibitorer | |
FI972160A (fi) | Matriisimetalloproteaasi-inhibiittorit | |
ATE239755T1 (de) | Thrombin inhibitoren | |
DK1027332T3 (da) | Hidtil ukendte lactametalloproteaseinhibitorer | |
DK0958287T3 (da) | Sulfamidmetalloprotease-inhibitorer | |
NO996578D0 (no) | Urokinase-inhibitorer | |
ATE230275T1 (de) | Angiogense-inhibitor | |
NO995434L (no) | Proteaseinhibitorer | |
NO995435D0 (no) | Protease-inhibitorer | |
NO995268D0 (no) | Proteaseinhibitorer | |
EE9800044A (et) | Prolüülendopeptidaasi inhibiitorid | |
DE69523450T2 (de) | Inhibitor | |
DE69431454D1 (de) | Amylase Inhibitoren | |
BR9610514A (pt) | Inibidores cicloantihelmínticos | |
BR9612344A (pt) | Inibidores de proteases |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MM1K | Lapsed by not paying the annual fees |
Free format text: LAPSED IN SEPTEMBER 2002 |